Diclofenac: Uses, Mechanism, Side Effects and Contraindications

Diclofenac Sodium 50 mg gastro-resistant tablets box, 20 tablets

Introduction

Diclofenac is one of the most widely used non-steroidal anti-inflammatory drugs (NSAIDs) worldwide. It is a cornerstone in the management of both acute and chronic pain conditions, valued for its potent analgesic, anti-inflammatory, and antipyretic properties.

While often discussed for rapid relief of dental pain, post-operative pain, dysmenorrhea, and musculoskeletal injuries, diclofenac requires a thorough understanding of its benefits versus its well-documented risks to the gastrointestinal, cardiovascular, and renal systems. Choosing between its two most common salt forms, diclofenac sodium and diclofenac potassium, is a key clinical decision that directly impacts onset of action and therapeutic indication.

This overview provides a detailed, evidence-based review of diclofenac for healthcare students, pharmacists, and the general public seeking reliable information.

What Is Diclofenac?

Diclofenac is a synthetic phenylacetic acid derivative NSAID. It was first introduced in 1973 and is available in multiple formulations including immediate-release tablets, enteric-coated tablets, extended-release tablets, oral powder for solution, rectal suppositories, topical gel 1% and 2%, topical solution, transdermal patch, and ophthalmic drops.

Chemically, diclofenac exists as a sodium or potassium salt to improve its solubility and pharmacokinetic profile. Both salts contain the same active moiety, diclofenac, but their pharmaceutical properties lead to distinct clinical applications. It is available worldwide under brand names such as Voltaren, Cataflam, Voltfast, and Diclofen-P.

Drug Class and Mechanism of Action

Drug Class: Non-Steroidal Anti-Inflammatory Drug (NSAID), Acetic Acid Derivative.
Mechanism of Action: Diclofenac exerts its therapeutic effects primarily by inhibiting the cyclooxygenase (COX) enzymes. COX enzymes are responsible for converting arachidonic acid into prostaglandins, prostacyclin, and thromboxane, which are lipid mediators of inflammation, pain, and fever.

There are two major isoforms:

COX-1: Constitutively expressed and responsible for maintaining gastric mucosal protection, renal blood flow, and platelet aggregation.
COX-2: Inducible at sites of inflammation and responsible for producing pro-inflammatory prostaglandins.

Diclofenac is considered a non-selective COX inhibitor but exhibits a relative preferential inhibition for COX-2 over COX-1. This is approximately 3 to 4 times more potent against COX-2 in vitro, which contributes to its strong anti-inflammatory efficacy. By blocking prostaglandin E2 (PGE2) synthesis in peripheral tissues and the central nervous system, diclofenac reduces peripheral sensitization of pain receptors, decreases vasodilation and edema, and lowers the hypothalamic set-point for fever.

Recent research also suggests additional mechanisms including inhibition of the lipoxygenase pathway and modulation of nociceptive processing in the spinal cord, which may explain its pronounced analgesic effect compared to some other NSAIDs.

Medical Uses and Indications

Diclofenac is indicated for the management of mild-to-moderate pain and inflammation. Its use is approved for a wide spectrum of conditions:

Musculoskeletal and Joint Disorders: The cornerstone indication. Used for symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis. It reduces joint pain, swelling, morning stiffness, and improves functional capacity. The sodium extended-release form is preferred for chronic management.
Acute Pain and Injury: Widely used for acute musculoskeletal pain, sprains, strains, contusions, sports injuries, back pain, and post-operative pain following orthopedic, dental, or general surgical procedures. The potassium immediate-release form is preferred here due to its rapid onset.
Migraine and Severe Headaches: Diclofenac potassium powder for oral solution 50 mg is FDA-approved for acute treatment of migraine attacks with or without aura. Its rapid absorption provides pain relief as early as 30 minutes.
Gynecological Conditions: Effective for primary dysmenorrhea. By inhibiting uterine prostaglandin production, it reduces uterine hypercontractility and alleviates painful menstrual cramps and associated symptoms.
Other Indications: Renal colic, acute gout attacks, and as ophthalmic drops for post-operative ocular inflammation and pain following cataract surgery.
Local and Topical Applications: Topical gels, patches, and solutions are recommended by international guidelines as first-line for localized osteoarthritis of the knees and hands, and for localized soft tissue inflammation such as tendinitis and bursitis. This route minimizes systemic exposure and associated risks.

Pharmacokinetics (ADME)

Absorption

This is where the salt form is critical:

Diclofenac Potassium: Features rapid dissolution in the acidic gastric environment. Peak plasma concentration (Tmax) is reached within 20-60 minutes. High bioavailability for fast analgesia.
Diclofenac Sodium: Enteric-coated tablets resist gastric dissolution and are absorbed in the duodenum, delaying Tmax to 2-3 hours. Extended-release forms have Tmax of 4-5 hours and provide sustained plasma levels.

Oral bioavailability is approximately 50-60% due to first-pass metabolism. Taking with food may slightly delay absorption but is often recommended for gastric tolerance.

Distribution

Diclofenac is highly bound to plasma proteins, more than 99% to albumin. It has a relatively small volume of distribution (0.12-0.17 L/kg). It penetrates well into synovial fluid, where concentrations remain higher than in plasma for longer, explaining its prolonged effect in joints despite a short plasma half-life. It also crosses the placenta.

Metabolism

Extensively metabolized in the liver primarily by cytochrome P450 isoenzyme CYP2C9 to 4'-hydroxydiclofenac, which retains some weak activity, and other inactive metabolites including 5-hydroxy and 3'-hydroxy metabolites. Glucuronidation also occurs.

Excretion

Plasma elimination half-life is short, 1-2 hours for immediate-release and 4-8 hours for sustained-release formulations. However, the biological half-life in synovial fluid is 3-6 hours. Approximately 60% of the dose is excreted in urine as glucuronide conjugates and metabolites, and 30% in feces via bile.

Dosage and Administration - General Information

This section is for general educational information only. The exact dose, salt form, and duration must be determined exclusively by a qualified healthcare professional based on age, indication, medical history, and concomitant medications. Do not self-medicate.

General principles discussed in official labeling include:

Lowest Effective Dose Principle: Due to cardiovascular and gastrointestinal risks, diclofenac should be used at the lowest effective dose for the shortest duration consistent with treatment goals.
Administration with Food: Oral formulations are generally recommended to be taken with food or a full glass of milk to minimize gastrointestinal discomfort, although this may slightly delay onset.
Swallowing Instructions: Enteric-coated and prolonged-release tablets must be swallowed whole, not crushed, split, or chewed, to preserve the protective coating and release mechanism.
Topical Use: Apply only to intact, non-inflamed skin. Do not apply to open wounds, eczema, or infected areas. Avoid contact with eyes and mucous membranes. Wash hands thoroughly after application unless hands are the treated area. Do not use with occlusive dressings unless directed.
Missed Dose: If a dose is missed, take it as soon as remembered. If it is almost time for the next dose, skip the missed dose. Do not double the dose.

Side Effects and Adverse Reactions

Adverse effects are dose and duration dependent.

Common Effects (1-10%)

Gastrointestinal: Dyspepsia, nausea, epigastric pain, abdominal cramps, flatulence, diarrhea, or constipation.
Central Nervous System: Headache, dizziness, drowsiness, vertigo.
Dermatologic: Rash, pruritus, especially with topical use: application site redness, dryness, and itching.
Other: Elevated transaminases, tinnitus, fluid retention.

Serious Risks - Seek Immediate Medical Attention

Gastrointestinal Ulceration, Bleeding, and Perforation: Can occur at any time without warning symptoms. Risk is higher in elderly, those with prior ulcer history, concurrent use of corticosteroids, anticoagulants, or prolonged use.
Cardiovascular Thrombotic Events: NSAIDs, including diclofenac, carry a boxed warning for increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. Risk may increase with duration of use and in patients with cardiovascular disease or risk factors. Diclofenac has one of the higher cardiovascular risks among non-selective NSAIDs.
Renal Toxicity: Can cause fluid retention, edema, hypertension, hyperkalemia, acute kidney injury, papillary necrosis, and worsening of chronic kidney disease due to inhibition of renal prostaglandins.
Hepatotoxicity: Rare but potentially severe. May cause marked elevations of ALT/AST, hepatitis, and rare cases of fulminant hepatic failure. Liver function monitoring may be advised in long-term therapy.
Hypersensitivity Reactions: Anaphylaxis, bronchospasm in aspirin-sensitive asthma patients, and severe cutaneous adverse reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hematologic: Anemia, thrombocytopenia, and inhibition of platelet aggregation.

Contraindications and Precautions

Contraindications

Diclofenac is contraindicated in:

Known hypersensitivity to diclofenac or any component of the formulation.
History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
For peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
Active gastrointestinal bleeding or active peptic ulcer disease.
Severe heart failure (NYHA Class IV), severe hepatic failure, or advanced renal disease.
Third trimester of pregnancy.

Precautions

Use with extreme caution in elderly, patients with history of GI disease, cardiovascular disease, hypertension, heart failure, renal impairment, liver dysfunction, coagulopathy, or those on anticoagulants. Monitor blood pressure, renal function, complete blood count, and liver enzymes during chronic therapy.

Drug Interactions

Anticoagulants and Antiplatelets: Co-administration with warfarin, heparin, apixaban, rivaroxaban, clopidogrel, or low-dose aspirin significantly increases risk of bleeding. Monitor INR if on warfarin.
Other NSAIDs and Corticosteroids: Concurrent use increases risk of GI ulceration and bleeding. Avoid dual NSAID therapy.
Antihypertensives and Diuretics: Diclofenac can attenuate the effect of ACE inhibitors (lisinopril), ARBs (losartan), beta-blockers, and diuretics (furosemide, hydrochlorothiazide). It also increases risk of renal dysfunction and hyperkalemia when combined with ACE inhibitors/ARBs and potassium-sparing diuretics. This combination is known as the "triple whammy."
Lithium and Methotrexate: NSAIDs reduce renal clearance of lithium and methotrexate, increasing their toxicity.
CYP2C9 Inhibitors/Inducers: Voriconazole (inhibitor) increases diclofenac exposure. Rifampin (inducer) may decrease efficacy.
SSRIs: Selective serotonin reuptake inhibitors increase bleeding risk when combined with NSAIDs.

Gastroprotective co-therapy with a proton pump inhibitor like omeprazole may be prescribed for high-risk patients, but it does not protect against lower GI or cardiovascular risks.

Pregnancy and Breastfeeding

Use during pregnancy must be strictly determined by a physician based on a careful risk-benefit assessment. Diclofenac is generally avoided, especially after 20 weeks gestation. The U.S. FDA recommends avoiding NSAIDs from 20 weeks onward due to risk of fetal renal dysfunction leading to oligohydramnios and low amniotic fluid. After 30 weeks, use is contraindicated due to risk of premature closure of the fetal ductus arteriosus and inhibition of labor.

During breastfeeding, diclofenac is excreted in very small amounts into breast milk and is generally considered compatible with breastfeeding for short-term use under medical supervision, but consultation with a physician and pharmacist is mandatory.

Pharmacist's Counseling Points

Take exactly as prescribed, at the lowest dose for the shortest time needed.
For fast pain relief (toothache, migraine, period pain), the potassium form works faster. For chronic arthritis, the sodium enteric-coated or SR form provides longer control.
Take with food and a full glass of water to reduce stomach upset. Avoid alcohol and smoking, which increase ulcer risk.
Do not combine with other pain relievers like ibuprofen, naproxen, or ketorolac without asking your doctor.
Report warning signs: black tarry stools, vomiting blood, severe stomach pain, chest pain, shortness of breath, weakness on one side, slurred speech, swelling of legs, unexplained weight gain, or skin rash.
Check blood pressure regularly, as NSAIDs can raise it.
If you have heart disease, hypertension, kidney disease, asthma, or history of ulcer, inform your doctor before starting.
For topical gel, apply 2-4 grams to the affected area 3-4 times daily and do not apply heat or tight bandages over it.
Store at room temperature away from moisture and keep out of reach of children.

Frequently Asked Questions (FAQs)

What is the main difference between Diclofenac Sodium and Diclofenac Potassium? Both contain the same active drug. Diclofenac potassium is absorbed much more rapidly, reaching peak levels in 20-60 minutes, making it ideal for fast pain relief like acute headaches, dental pain, or dysmenorrhea. Diclofenac sodium, especially enteric-coated or SR tablets, is absorbed slowly, providing a sustained effect better suited for chronic joint inflammation like osteoarthritis and rheumatoid arthritis.

Can I apply Diclofenac gel and take oral Diclofenac at the same time? Generally, systemic duplication should be avoided unless explicitly directed by a physician. Even topical diclofenac has some systemic absorption, and combining routes increases overall drug exposure and the risk of gastrointestinal, cardiovascular, and renal side effects.

Does Diclofenac cause stomach ulcers? Yes, like other traditional NSAIDs, long-term or high-dose use inhibits protective gastric prostaglandins, increasing the risk of gastritis, erosions, and ulcers. Taking it with food, using the lowest effective dose, and co-prescribing a gastric protector like a PPI in high-risk patients helps mitigate, but not eliminate, this risk.

Is Diclofenac stronger than ibuprofen? On a milligram basis, diclofenac is considered more potent than ibuprofen and often requires lower doses for similar analgesia. However, "stronger" does not mean safer; diclofenac has a higher reported risk of cardiovascular events compared to ibuprofen and naproxen in some studies.

How long does Diclofenac take to work? Diclofenac potassium tablets may start relieving pain within 20-30 minutes. Sodium enteric-coated tablets may take 1-2.5 hours. Topical gel may take a few days of regular use to achieve full effect for arthritis pain.

References

Medical Disclaimer

This content is for educational and informational purposes only and does not provide medical advice, diagnosis, or treatment. It is not a substitute for professional medical judgment. Always consult a qualified healthcare provider with any questions you may have regarding a medical condition or medication. Do not take, start, stop, or change the dose of any medication without a valid prescription and counseling from your physician or pharmacist. In case of medical emergency, seek immediate medical attention.

Written & Reviewed by: Dr. Abdulelah Bandar Mohammed Ahmed, PharmD Last Updated: November 1, 2026 | Originally Published: October 29, 2026

Edit This Article